CMS New Tech Town Hall: Industry Insists Bonus Threshold Is Too High
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's Wingspan intracranial stent is the only product under consideration for a new technology add-on payment in fiscal year 2008, prompting stakeholders to complain that the opaqueness of CMS' criteria for awarding the bonus payment has deterred most firms from even applying
You may also be interested in...
New-Tech Inpatient Bonus Payments May Take Hiatus In FY 2008
Fiscal 2008 could be the first year that CMS makes no "new technology" bonus hospital inpatient payments since it began accepting industry applications for such payments in 2002
New-Tech Inpatient Bonus Payments May Take Hiatus In FY 2008
Fiscal 2008 could be the first year that CMS makes no "new technology" bonus hospital inpatient payments since it began accepting industry applications for such payments in 2002
Enough Is Enough For New Technology Hospital Payments, MedPAC Says
Medicare hospital payments adequately cover the cost of new technologies and, in some cases, may overcompensate, the Medicare Payment Advisory Commission suggests in its March 1 1report to Congress